Prospera Financial Services Inc Biomarin Pharmaceutical Inc Transaction History

Prospera Financial Services Inc

  • $3.5 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $182,775 - $236,226
2,398 New
2,398 $231,000
Q2 2022

Aug 08, 2022
SELL
$71.48 - $86.85 $15,582 - $18,933
-218 Reduced 12.95%
1,466 $121,000
Q1 2022

May 04, 2022
BUY
$74.28 - $92.69 $125,087 - $156,089
1,684 New
1,684 $130,000
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $27,228 - $33,825
-375 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$71.87 - $131.03 $26,951 - $49,136
375 New
375 $29,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email